The global primary cell culture market size is expected to reach USD 5.4 billion by 2025 and is expected to register a CAGR 10.6% during the forecast period,according to a new report by Grand View Research, Inc. Growth in production of vaccines, monoclonal antibodies, and regenerative medicines, patent expiration of blockbuster biologics, and rising demand for stem cell therapy and tissue engineering are factors promoting the growth of this market. These trends are attracting big players in healthcare and medical research toward this field.
Primary
cell culture is increasingly being used in fields such as drug screening,
organogenesis, disease diagnosis, biological product manufacturing, cancer
research, and stem cell research. Due to their increased use in various
healthcare domains, private medical organizations, pharmaceutical and biotech
companies, education, research and government organizations have increased
their investments and funding in this market.
Primary
cells show high physiological resemblance to the tissues and organs they are
extracted from. This provides immense help to researchers and scientists in
understanding various complexities related to drug pathways, studying diseases
and drug development, and their effect on biological site of action in-vivo.
Due to these qualities, their use has increased in biopharmaceuticals,
transplants, and chronic disease therapies. Their sprouting customized use for
different research purposes is also a key trend in the industry.
However,
there are many ethical concerns over the usage of human embryonic cells, which
poses as a major restraint in the growth of this market. Usage of transgenic
plants and animals and stem cells, as well as stringent rules and regulations
associated with it, will also negatively affect market growth in the years to come.
Currently,
North America holds the largest share in the market, with Asia Pacific expected
to witness the fastest growth during the forecast period. This can be
attributed to rising per capita incomes, growing healthcare affordability, and
improving economic status of countries such as India and China.
Commercial
players in this market are mostly established companies; however, several new
players have been making their presence known in recent years. Some of the key
players are Merck KGaA; Lonza; Promocell GmbH; GE Healthcare; and Corning, Inc.
Full Research Report On Primary Cell Culture Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/primary-cell-culture-market
Primary Cell
Culture Market Report Highlights
- Growing need
for stem cells transplants and increasing number of clinical research
studies and medical therapies for chronic diseases are expected to drive
the market
- Increasing
prevalence of chronic illnesses all over the world and ongoing researches
in several therapeutic areas has resulted in rapid advancements in stem
cell therapy, cancer treatment, gene therapy, and regenerative medicine
- While media
held the dominant share by way of product, the reagents and supplements
segment is expected to register a CAGR of 10.8% during the forecast period
- On the basis
of separation and culture technique, enzymatic disaggregation held the
dominant share in 2017. This is due to high productivity yield and less
damage associated with this technique. Enzymes widely used for carrying
out degradation process include trypsin, collagenase, and papain
- North America
holds the largest revenue share in the market. Registering a CAGR of 12.2%
during the forecast period, Asia Pacific is poised to emerge as the
fastest growing region in the coming years
- Lonza, Merck,
Thermo Fisher, and GE Healthineers are some of the leading players in this
market. The number of new players venturing in this space is increasing
each year.
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/primary-cell-culture-market/request/rs1
Primary Cell
Culture Market Segmentation
Grand View Research has
segmented the global primary cell culture market based on product, application,
separation and culture technique, and region:
Primary Cell
Culture Product Outlook (Revenue, USD Million, 2014 - 2025)
- Primary Cell
- Fat
- Blood
- Nerve
- Bone
- Endothelial
- Skin
- Muscle
- Stem
- Others
- Reagents and Supplements
- Attachment Solutions
- Buffers and Salts
- Freezing Media
- Sera
- Growth Factors and Cytokines
- Others
- Media
- Fat Media
- Blood Media
- Nerve Media
- Bone Media
- Endothelial Media
- Skin Media
- Muscle Media
- Stem Media
- Others
Primary Cell
Culture Application Outlook (Revenue, USD Million, 2014 - 2025)
- Tissue Culture & Tissue Engineering
- Vaccine Production
- Gene Therapy and Regenerative Medicine
- Toxicity Testing and Drug Screening
- Cancer Research
- Model System
- Virology
- Prenatal Diagnosis
- Stem Cell Therapy
- Others
Primary Cell
Culture Separation and Culture Techniques Outlook (Revenue, USD Million, 2014 -
2025)
- Explant Method
- Enzymatic Disaggregation
- Trypsin
- Collagenase
- Protease
- Pronase
- Dispase
- Hyaluronidase
- Neuraminidase
- Elastase
- DNase
- Papain
- Accutase
- Others
- Mechanical Separation
- Others
Primary Cell
Culture Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Asia Pacific
- China
- Japan
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- South Africa
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment